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As the most abundant inhibitory neurotransmitter in the mammalian brain, γ -aminobutyric 
acid (GABA) plays a crucial role in shaping the frequency and amplitude of oscillations, which 
suggests a role for GABA in shaping the topography of functional connectivity and activity. 
This study explored the effects of pharmacologically blocking the reuptake of GABA (increas- 
ing local concentrations) using the GABA transporter 1 (GAT1) blocker, tiagabine (15 mg). In 
a placebo-controlled crossover design, we collected resting magnetoencephalography (MEG) 
recordings from 15 healthy individuals prior to, and at 1-, 3- and 5- hours post, administration 
of tiagabine and placebo. We quantified whole brain activity and functional connectivity in dis- 
crete frequency bands. Drug-by-session (2 × 4) analysis of variance in connectivity revealed 
interaction and main effects. Post-hoc permutation testing of each post-drug recording vs. re- 
spective pre-drug baseline revealed consistent reductions of a bilateral occipital network span- 
ning theta, alpha and beta frequencies, across 1- 3- and 5- hour recordings following tiagabine 
only. The same analysis applied to activity revealed significant increases across frontal regions, 
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coupled with reductions in posterior regions, across delta, theta, alpha and beta frequencies. 
Crucially, the spatial distribution of tiagabine-induced changes overlap with group-averaged 
maps of the distribution of GABA A receptors, from flumazenil (FMZ-V T ) PET, demonstrating a 
link between GABA availability, GABA A receptor distribution, and low-frequency network os- 
cillations. Our results indicate that the relationship between PET receptor distributions and 
MEG effects warrants further exploration, since elucidating the nature of this relationship may 
uncover electrophysiologically-derived maps of oscillatory activity as sensitive, time-resolved, 
and targeted receptor-mapping tools for pharmacological imaging. 
© 2021 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY 

























































































here is a pressing need to develop time-resolved non- 
nvasive markers of pharmacological effects within the 
rain, that can be used to both drive our understanding 
f brain function but also demonstrate the action and 
emporal dynamics of novel pharmacological agents. This 
ould help reduce the very significant costs associated 
ith the development of new drugs, by helping to demon- 
trate direct target engagement, and therefore accelerate 
he development of novel treatments for diseases that 
ave significant societal burdens. One strong candidate 
or such a marker are neural oscillations, either mod- 
lated by task or characterised at rest. Unlike indirect 
unctional magnetic resonance imaging (fMRI), neural os- 
illations measured using non-invasive methods, such as 
agnetoencephalography (MEG), arise directly from the 
ynchronous oscillatory-activation of post-synaptic cur- 
ents in ensembles of principal cells in cortex ( Brunel and 
ang, 2003 ; Buzsáki et al., 2004 ; Wang, 2010 ), predom- 
nantly those in superficial layers ( Buzsáki et al., 2012 ; 
ing et al., 2012 ). Converging evidence from experimen- 
al ( Kramer et al., 2008 ; Whittington et al., 1995 ) and 
omputational ( Brunel and Wang, 2003 ; Pinotsis et al., 
013 ; Shaw et al., 2017 ) studies suggests that the at- 
ributes of these oscillations – peak frequency and 
mplitude – are determined by more fundamental, un- 
bserved, neurophysiological processes. For example, the 
eak frequency of oscillations across many frequency 
ands has been linked with inhibitory neurotransmission 
 Buzsáki et al., 2004 ; Hall et al., 2011 ; Roopun et al., 2006 ;
hittington et al., 2000 ) mediated by γ -aminobutyric acid 
GABA). 
The link between GABA and macroscopic oscillations ob- 
erved in MEG is likely mediated by the functional in- 
ibitory role of GABA receptors, which are broadly cat- 
gorised as fast, ionotropic GABA A and slower G-protein 
oupled GABA B , although there exist subtypes of each 
 Belelli et al., 2009 ; Vargas, 2018 ; Whiting, 2003 ). The cur-
ents mediated by both of these receptor types have been 
mplicated in oscillation generation through control of re- 
urrent excitation-inhibition ( Atallah and Scanziani, 2009 ; 
runel and Wang, 2003 ; Galarreta and Hestrin, 1998 ; 
ohl and Paulsen, 2010 ; Krupa et al., 2014 ), whereby the 
ABAergically-mediated inhibitory currents exert tempo- 
al control over the firing and activity of excitatory prin- 35 ipal cells ( Bartos et al., 2007 ; Whittington et al., 2000 ).
n the case of higher-frequency oscillations, including beta 
13 - 30 Hz) and gamma (30 + Hz), the peak frequency 
ay be dependant on the balance of excitatory and in- 
ibitory currents ( Brunel and Wang, 2003 ; Kujala et al., 
015 ; Shaw et al., 2017 ), implicating excitatory glutamater- 
ic receptor types, such as α-amino-3–hydroxy-5-methyl-4- 
soxazolepropionic acid (AMPA) and N-methyl-D-aspartate 
NMDA). 
Pharmaco-MEG studies provide a framework for examin- 
ng the effects that pharmacological manipulation of neu- 
otransmitter or neuromodulator systems has on oscillatory 
ctivity. To date, studies of GABAergic drugs have primar- 
ly examined changes in task-induced fluctuations in oscil- 
ation metrics, usually confined to the analysis of one par- 
icular sensory system. For example, in the motor cortex, 
enzodiazepines, such as diazepam, modulate the ampli- 
ude of movement-related beta oscillations ( Hall et al., 
011 ; Jensen et al., 2005 ). In visual cortex, propofol, an 
gonist of GABA A receptors, increased the amplitude of 
amma oscillations and concurrently suppressed the ampli- 
ude of alpha oscillations ( Saxena et al., 2013 ). Tiagabine 
educed the frequency of stimulus-induced gamma oscilla- 
ions ( Magazzini et al., 2016 ). Alcohol, which has a complex 
inding profile including benzodiazepine-mediated GABA A 
ffects, decreased the frequency and increased the ampli- 
ude of gamma in the visual cortex ( Campbell et al., 2014 ).
or a summary of GABAergic pharmaco-MEG studies, see 
 Muthukumaraswamy, 2014 ; Nutt et al., 2015 ). These re- 
ults clearly demonstrate a role for GABA in shaping oscilla- 
ory responses, however they are confined to observations 
f task-related, local dynamics. 
Task-free, ‘resting state’ recordings of oscillations fo- 
us on correlation of fluctuations in different brain re- 
ions, within specific frequency bands. This functional con- 
ectivity approach rests on the assumption that discrete 
egions of the brain whose band-limited amplitude en- 
elopes are correlated, are functionally connected. Since 
ABA plays a role in shaping the oscillations of local 
within-region) dynamics, it is expected that it also shapes 
he topography of the networks formed by these regions 
nteracting. 
In the present study, we examined the effect of pharma- 
ologically blocking the reuptake of GABA using tiagabine, 
 GABA-transporter 1 (GAT1) blocker. We anticipated in- 
reased GABA availability would increase activation of 

























































































































ABAergic receptors and thereby GABAergic inhibition, 
hich would have a macroscopic effect of reducing func- 
ional connectivity strengths across frequency bands. 
Next, we examined the degree to which these changes 
verlap with the spatial distribution of GABA A receptors in 
 group-average map of flumazenil volume-of-distribution 
FMZ-V T ) PET. Here, we expected brain regions showing the 
ighest FMZ-V T (interpreted as density of GABA A receptors) 
ould also demonstrate the biggest drug-induced changes 
n oscillatory activity. 
. Experimental procedures 
.1. MEG methods 
.1.1. Sample 
ifteen healthy individuals (1 female, 14 male) aged between 20 
nd 32 (mean 25.5) completed a single-blind, placebo-controlled 
rossover study of 15 mg oral tiagabine (Gabitril) and placebo. 
tudy days were separated by at least a week, with each day con-
isting of 4 MEG scans; an initial ‘pre-drug’ recording, followed by 
ost-ingestion scans at 1, 3 and 5 h. MEG data from the active task
rotocols, including an overview of the design, has been published 
reviously ( Magazzini et al., 2016 ; Muthukumaraswamy et al., 
013 ). All study participants gave informed consent and the study 
rocedures were approved by the UK National Research Ethics Ser- 
ice (South East Wales). Volunteers were excluded if they reported 
ersonal history of psychiatric or neurological diagnosis, current 
ecreational or prescription drug use, or impaired liver function. 
articipants completed the Subject High Assessment Scale (SHAS) 
 Schuckit, 1980 ) immediately following the end of each scan. 
.1.2. Data acquisition 
hole head MEG recordings were obtained using a CTF275 ra- 
ial gradiometer system, with participants seated upright. Task- 
ree, ‘resting’ recordings of 10 min were obtained at 1200 Hz and 
nalysed as synthetic third-order gradiometers ( Vrba, 2001 ). Par- 
icipants were fitted with three electromagnetic head coils (na- 
ion and bilateral pre-auriculars), which remained fixed through- 
ut the study day, and were localized relative to the MEG sys- 
em immediately before and after recording. All study participants 
ad a T1-weighted MRI (1 mm isotropic) available for subsequent 
ource-space analysis. Co-registration was achieved by placement 
f fiduciary markers at fixed distances from anatomical landmarks 
asily identifiable on an anatomical MRI (tragus, eye centre). Of- 
ine, recordings were downsampled to 600 Hz and segmented into 
 s epochs. Each epoch was visually inspected for gross artefact 
e.g. movement, clenching, eye blinks) and removed from the 
nalysis. 
.1.3. Resting-state analysis pipeline 
e computed functional connectivity using the amplitude envelope 
orrelation (AEC) metric, which is interpretable, robust and repeat- 
ble ( Colclough et al., 2016 ). This coupling was computed sepa- 
ately for 7 distinct frequency bands using conventional definitions; 
elta (1 – 4 Hz), theta (4 – 8 Hz), alpha (8 – 13 Hz), beta (13 - 30 Hz)
nd 3 gamma windows (40 – 60, 60 – 80 and 80 – 100 Hz). Fig. 1
ummarises the analysis pipeline. 
Source analysis was performed using the linearly constrained 
inimum-variance (LCMV) beamformer, a spatial filtering method, 
s implemented in Fieldtrip ( Oostenveld et al., 2011 ). Using a local- 
pheres conductivity (forward) model, the beamformer estimated 
he temporal activity of each location of a 6 mm grid, as linear 
ombinations of the MEG channels. This step was repeated for each 
f the frequency bands of interest, with the covariance of the MEG 36 hannels being recomputed from appropriately band-pass filtered 
ata. For each of the locations on this grid, the estimated source
imeseries for each trial was concatenated to form a single time- 
eries for both connectivity and activity analysis. 
.1.4. Analysis of amplitude-amplitude connectivity 
ur analysis proceeded using the methods we employed in 
oelewijin et al. (2019 ). We first reduced the spatial dimension- 
lity of the source reconstructed data to a set of 90 anatomical
oci, described by the Automatic Anatomical Labelling (AAL90) at- 
as ( Tzourio-Mazoyer et al., 2002 ). We chose one grid source to
epresent each AAL90 region, selected based on the voxel having 
he largest temporal standard deviation across the resting-state 
xperiment. 
Having reduced to a set of 90 regions, the temporal activity 
f sources was orthogonalized with respect to each other region 
sing symmetric orthogonalization ( Colclough et al., 2015 ), which 
urther reduces source leakage. Next, the amplitude envelopes of 
ach region were extracted using the absolute of the (complex) an- 
lytical signal derived by Hilbert transform (in MATLAB). This time- 
eries was downsampled to a temporal resolution of 1 s in order to
tudy connectivity mediated by slow amplitude envelope changes 
 Brookes et al., 2011 ). A median filter was used to remove spikes or
ransients within the envelope. 
Functional connectivity of the 90 regions was calculated using 
ross-correlations of the amplitude envelopes of each region. Since 
orrelations are undirected, only the upper triangular portion (mi- 
us the diagonals) of the 90-by-90 correlation matrix was com- 
uted, requiring 4005 computations for each of the frequency bands 
ested, for each subject. In order to make these correlations more 
uitable for statistical analysis, and to correct for the varying length 
f the final timeseries for each person, each of these correlation co-
fficients were then transformed to variance-normalised Fisher z- 
tatistics, using a procedure that estimates the effective temporal 
ariance of the node timeseries’ null distribution using surrogates 
enerated by randomisation. 
We additionally adjusted each individual connectivity matrix to 
orrect for global session effects ( Siems et al., 2016 ). These ef-
ects can be generated by experimental session confounds effect- 
ng SNR, such as head-size, head-motion and position within the 
EG helmet. Such correction procedures are common in fMRI con- 
ectivity analyses, although there is much debate as to the opti- 
um algorithm to be used for post-hoc standardization ( Yan et al., 
013 ). Here we adopted a variant of z-scoring, in which the null
ean and standard-deviation of connectivity, across the matrix, is 
stimated by fitting a Gaussian ( Lowe et al., 1998 ) to the noise
eak ( + /- 1SD) of the distribution. This estimated mean and SD
s used to Z-score each Fisher’s Z connectivity value for that 
erson/session. 
Finally, in order to only analyse connections which are strongly 
resent in every person/session, we estimated the mean rank of 
very connection in the matrix and removed the weakest 80%. 
.1.5. Source activity analysis 
or each of the beamformer voxels on the 6 × 6 × 6 mm recon-
truction grid (5061 voxels), we estimated source activity for each 
oxel, frequency, person and session. Estimating raw power esti- 
ates from MEG/EEG data, in source-space, and comparing these 
cross people and sessions is problematic because geometrical ef- 
ects, which vary from session to session and across the brain, 
an lead to artefactual inter-session differences ( Luckhoo et al., 
014 ). This is particularly important for beamformer reconstruc- 
ions in which typical corrections for depth-biases in single-state 
lter weights can exacerbate these artefactual differences. Here, 
e use a normalised measure of “activity”, in which we estimate 
he amplitude envelope at each of the 5061 locations, using the 
ilbert methods described above, and calculate the temporal co- 
fficient of variation (CoV) i.e. the temporal standard deviation of 
European Neuropsychopharmacology 50 (2021) 34–45 

















































he envelope, divided by the mean of the envelope. Finally, we also 
-scored these activity measures using the same gaussian-fit proce- 
ure described above for our connectivity measures. 
.2. PET flumazenil methods 
.2.1. Sample 
 group of 16 healthy participants (females: 4, age range: 26–61 
ears, mean age: 46 years) were recruited as healthy controls for 
 clinical PET study. No participants in the study reported history 
f neuropsychiatric or neurological conditions or were on any pre- 
cribed medications. None of the participants consumed alcohol 
ithin 48 h prior to their PET-FMZ scan. All participants provided 
ritten informed consent according to the Declaration of Helsinki. 
pprovals from the UK Administration of Radioactive Substances 
dvisory Committee (ARSAC) and the Ethics Committee, Imperial 
ollege, Hammersmith Hospital, were obtained. For the creation 
f the FMZ template, data from six healthy participants with global 
alues close to the mean were selected and raw and right-left re- 
ersed (flipped) data were used (12 scans). 
.2.2. PET scan parameters and image analysis 
ynamic 3D PET data were collected on a 953B Siemens/CTI PET 
canner. Data consisted of 20 frames over a 90-minute time pe- 
iod. Scans were obtained with axial planes parallel to a horizontal 
lane passing through the anterior and posterior commissures. The 
racer, ̃ 370 MBq of [ 11 C]FMZ, was injected intravenously and arte- 
ial blood samples were collected in order to calculate the plasma 37 nput function with metabolite correction ( Hammers et al., 2003 ; 
ammertsma et al., 1993 ). 
Voxelwise parametric maps of [ 11 C]FMZ total volume-of- 
istribution (V T ) were calculated from the time-series data 
nd arterial plasma input functions with spectral analysis 
 Cunningham and Jones, 1993 ; Lassen et al., 1995 ), allowing for
 blood volume fraction, as detailed previously ( Hammers et al., 
008 ). 
.2.3. Template creation 
tatistical Parametric Mapping software was used to create the 
 
11 C]FMZ PET template (SPM99, Wellcome Trust Centre for Hu- 
an Neuroimaging, University College London, London, UK, https: 
/www.fil.ion.ucl.ac.uk/spm/software/spm99/ ). 
PET data were coregistered to the corresponding MRI data, and 
eft-right-reversed, but not resliced. The MRIs were normalised to 
he Montreal Neurological Institute standard space (MNI152). The 
ETs were spatially normalised using the same transformations as 
or the MRI images and written with voxel sizes of 2 × 2 × 2 mm.
ata were then averaged with a softmean function and smoothed 
ith an 8 mm (FWHM) Gaussian kernel to yield the final template. 
.2.4. Statistical analyses 
or connectivity and activity analyses, we employed a repeated- 
easures analysis of variance (RM-ANOVA), of drug (tiagabine, 
lacebo) by session (pre and 1-, 3- and 5-hours post). Where drug
 session interaction effects were present, we employed post-hoc 












































































































aired-t testing to explore how effects evolved dynamically across 
essions (time). 
For connectivity analyses, computed in AAL90 space for com- 
utational tractability, we employed randomisation based post- 
oc testing with omnibus-correction ( Nichols and Holmes, 2001 ). 
or the activity analysis, performed at the voxel level 
‘voxelwise’), permutation testing was not computationally 
ractable; as such we employed false-discovery-rate (FDR) correc- 
ion ( Benjamini and Hochberg, 1995 ). For the comparison of the 
patial distribution of activity effects with the PET FMZ V T tem- 
late, we used randomisation-based Pearson’s correlation (5000 
ermutations) with omnibus correction. 
. Results 
.1. Functional connectivity 
upplementary Fig. 1 (S1) shows connections (edges) 
emonstrating significant drug-by-session interaction for 
ach frequency band (top row), as well as edges showing a 
ain effect of drug (middle row) and session (bottom row), 
s computed by RM-ANOVA. Connections showing significant 
nteraction effects were observed in alpha ( n = 83), beta 
62), theta (61) and delta (7) bands, with most connections 
lustered around posterior regions (occipital / parietal). 
here were no edges in the gamma range demonstrating an 
nteraction effect (Fig. S1 demonstrates only gamma 1 , 40 –
0 Hz, however the negative result was also observed in the 
igher gamma bands). Connections showing a main effect of 
rug were observed in theta ( n = 96 edges), alpha (58), beta 
33) and delta (20), largely confined to posterior regions but 
ncluding interactions with cingulate and temporal regions 
n the alpha band. Effects of session were observed across 
ll frequency bands ( n = 130 edges in alpha, 111 in beta, 48
n theta, 22 in delta and 3 in gamma 1 ). Again, these were 
osteriorly focussed but included interactions with frontal, 
eep (delta) and temporal (theta) regions. A list of the top- 
 strongest (significant) edges for each frequency band, and 
ach term (effect), are listed in supplementary Table 1. 
Post-hoc permutation-based randomisation testing of 
ithin-drug session effects revealed significant reductions 
 Fig. 2 (A), blue lines) of edge strength for tiagabine at 1, 3
nd 5 hr vs. pre, across delta, theta, alpha and beta. Anal- 
sis of the topography revealed these reductions were con- 
ned to occipital cortices. Increases were observed at two 
rontal edges (1 at 3 h, 1 at 5 h) in the delta band. Sig-
ificant increases in edge strength were observed between 
rontal and temporal regions (3 h vs pre) and temporal and 
eep regions (5 h vs pre) across all three gamma windows 
or placebo. No other within-drug-vs.-pre changes in edge 
trength were observed for placebo. A list of all significant 
dges for each frequency band and each comparison ( n = 6; 
, 3 and 5 h vs. pre for each drug) are listed in supplemen-
ary Table 2. Fig. 2(B) summarises the ‘time-course’ of ef- 
ects on occipital connectivity for each post-drug session vs 
re. 
.2. Source activity 
ig. 3 shows the voxels whose ‘activity’ demonstrated sig- 
ificant drug-by-session interaction, for each frequency 38 and (i.e. voxels with p < 0.05 after false recovery rate 
orrection (FDR)) ( Benjamini and Hochberg, 1995 ). Signifi- 
ant drug x session interaction effects on activity were ob- 
erved in alpha ( n = 3133 voxels), beta ( n = 1900), theta
 n = 1776) and delta ( n = 1539, see Fig. 3 (B)) but not
amma. Within each band, peak F-statistics in size order 
ere F(1,14) = 120.37 (theta), F(1,14) = 106.43 (beta), 
(1,14) = 72.87 (delta) and F(1,14) = 67.62 (alpha). These 
re summarised in Fig. 3 (B). 
Post-hoc paired-t tests between post-drug time points 
ersus the pre-drug recording, were computed for vox- 
ls demonstrating significant interaction effects in the re- 
eated measures ANOVA. The resulting t-difference maps 
or each frequency band, shown for tiagabine in Fig. 4 (A), 
epict a pattern common across frequencies whereby 
rontal regions demonstrated increased activity and poste- 
ior regions decreased activity, in post-tiagabine sessions 
elative to pre-drug (this is shown only for tiagabine in 
ig. 4 , not placebo). Fig. 4 (B) summarises the time-course 
f these paired-t effects over all sessions (all post-drug vs 
re, for both tiagabine and placebo sessions). 
.3. Correlation between the spatial distribution 
f drug effects and mean flumazenil pet measures 
e observed significant correlations (randomisation testing 
ith 5000 permutations and omnibus correction) in the spa- 
ial distribution of the mean drug effects on activity (i.e. 
bsolute paired-t value of drug vs pre) with scaled FMZ V T , 
cross delta ( r = 0.15, 0.25 and 0.2 at 1, 3 and 5 h, re-
pectively), theta ( r = 0.15, 0.26 and 0.19 at 1, 3 and 5 h,
espectively), alpha ( r = 0.18, 0.22 and 0.24 at 1, 3 and
 h, respectively) and beta ( r = 0.21, 0.23 and 0.24 at 1, 3
nd 5 h, respectively). These correlations suggest that the 
agnitude of drug effects on activity, irrespective of sign, 
ended to be bigger in regions with higher FMZ V T ( Fig. 5 ). 
. Discussion 
ur results indicate that pharmacologically increased GABA 
vailability leads to reductions of both local activity and 
egional connectivity across low frequencies from delta, 
hrough to higher, beta frequencies. Connectivity effects 
re localised to posterior brain regions, with predominant 
ffects in occipital lobe. Fig. 2 (B) summarises the time 
ourse of mean effects for the connectivity, averaged across 
ccipital regions, showing delta, theta, alpha and beta. Vox- 
lwise analysis of ‘activity’ (temporal coefficient of varia- 
ion) in each frequency band also demonstrated tiagabine 
nduced reductions in posterior regions ( Fig. 4 ), that were 
ccompanied by increases in activity in frontal regions. 
ig. 4 (B) summarises the time course of activity effects for 
ach frequency band. 
As summarised in Fig. 2 (B), the effects of tiagabine on 
unctional connectivity across the four frequency bands 
how a similar temporal pattern, suggesting a common 
echanism for the observed effects that is not frequency 
pecific. This wide-band effect is consistent with theories 
f GABAergic function as a crucial component of oscilla- 
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Fig. 2 (A) Topographical representation of the post-hoc permutation-based (5k) tests, showing only significant ( p < 0.05) connec- 
tions, for within-drug comparisons to baseline (1-, 3- and 5- hours vs. pre). Colour represents direction (red = increased vs. pre, 
blue = decreased vs. pre). (B) Time course of mean occipital connectivity effects for post-drug vs. baseline, for placebo (PLA) and 
tiagabine (TGB). Colours represent frequency bands. Note that the Placebo and Tiagabine sessions were performed on different 























ion generation, whereby inhibitory GABAergic currents ex- 
rt temporal control over principal excitatory populations. 
Using a ‘template’ map of flumazenil V T , which is a quan- 
itative measure of flumazenil binding at GABA A receptors, 
e demonstrated that the distribution of drug-induced ef- 
ects in activity, as measured by the absolute paired-t value 
f post-drug vs pre, correlated with the distribution of 
ABA A receptors across the brain ( Fig. 5 ). In other words, 
egions with higher flumazenil binding also demonstrated 
igger effects of drug on activity in delta, theta, alpha and 
eta bands. The ‘time course’ of this correlation across 
EG session is summarised in Fig. 5 (B). Interestingly, this 39 ime course suggests that the drug effects peak around the 
th hour scan, whereas self-reported subjective high, us- 
ng the SHAS, peaks between the 1st and 3rd hours (supple- 
entary Fig., S2), and had reduced by the 5th hour scan. 
hile our limited sample size limits us from exploring this 
nteresting discrepancy further in the present data, follow 
p studies with sufficient power to explore individual dif- 
erences should explore this temporal dissociation between 
he peak in subjective effects and the peak in imaging 
etrics. 
Previous studies have suggested that tiagabine is not 
irectly active at GABA A sites, instead exerting effects 
A.D. Shaw, H.L. Chandler, K. Hamandi et al. 
Fig. 3 (A) Surface representation of the voxels demonstrating significant ( p < 0.05) drug-by-session interaction effects on source 
activity (from RM-ANOVA). Red-Yellow colour axis represents relative strength of F-statistic for significant voxels ( p < 0.05 FDR 
corrected). Black = n .s. (B) Summary plots for the voxelwise drug-by-session repeated-measures ANOVA, for source activity, showing 
(inset a) the number of significant voxels in each frequency band ( p < 0.05 FDR corrected) and (inset b) the maximum F-statistic in 
each frequency band. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version 














n the GABAergic system through inhibiting reuptake of 
ABA predominantly through GABA transporter 1 (GAT1) 
 Madsen et al., 2011 ; Ransom and Richerson, 2009 ) 
nd the extrasynaptic betaine/GABA transporter BGT1 
 Madsen et al., 2011 ). 
Despite this lack of binding profile at GABA A sites, 
iagabine increases the decay time of GABA A mediated in- 40 ibitory postsynaptic currents (IPSCs) ( Thompson and Gäh- 
iler, 1992 ) and increases the affinity of GABA A receptors 
ontaining the benzodiazepine site to GABA ( Frankle et al., 
009 ). This is important, since it links increased availabil- 
ty of GABA (through inhibited reuptake) to a functional 
ffect or consequence, in the form of increased affin- 
ty and IPSC decay time. In other words, it demonstrates 
European Neuropsychopharmacology 50 (2021) 34–45 
Fig. 4 (A) Surface representation of the significant ( p < 0.05 FDR corrected) post-hoc paired-t values for post-tiagabine vs pre, for 
activity measures in each frequency band. The post-drug session depicted was chosen based on the session showing the maximum 
number of significant voxels. For delta and theta, this was 3 hr post tiagabine vs pre, whereas for alpha and beta it was 5 hr post 
tiagabine vs pre. Colour axis represents direction of effect, with red/yellow representing significant, positive t-values, blue/purple 
representing significant negative t-values and black representing non-significant voxels. (B) Summary of the source activity post-hoc 
paired-t effects for post-drug vs pre for each session. (inset a) shows the number of significant ( p < 0.05 FDR corrected) voxels for 
each frequency band. (inset b) shows the corresponding peak significant paired t-value for each comparison (x-axis) and frequency 
band. For clarity, the strongest positive and negative t-values are presented separately. Note that the Placebo (PLA) and Tiagabine 
(TGB) sessions were performed on different days. (For interpretation of the references to colour in this figure legend, the reader is 
referred to the web version of this article.) 
41 
A.D. Shaw, H.L. Chandler, K. Hamandi et al. 
Fig. 5 (A) Spatial distribution of scaled flumazenil FMZ VT correlations with effects of drug (absolute t value) on activity across 
frequency bands delta (top), theta, alpha and beta (bottom). Dots represent individual voxels, colour coded by AAL region to which 
they belong. Statistics (r and p-value) are derived from randomisation-corrected Pearson correlations with omnibus correction for 
multiple comparisons. Note that because of inherent spatial smoothing within both the PET and MEG beamformer maps, the p- 
values listed here are likely to be artificially small. (B) Summarising the spatial correlation of flumazenil volume-of-distribution 




















































hat merely increasing the amount of GABA with tiagabine 
oes have a downstream effect on GABAergic function, via 
 GABA A mediated phenomenon. As such, our findings of 
iagabine-attenuated functional connectivity and activity 
t low frequencies across posterior cortex may reflect en- 
anced GABAergic function in the form of lengthened IP- 
Cs. The correlation in spatial effects between activity and 
template, canonical) FMZ V T supports this, because the ef- 
ects are spatially colocalised to regions with a higher den- 
ity of GABA A receptors. 
The above argument cannot, however, explain the sig- 
ificant increases in activity observed in frontal regions 
fter administration of tiagabine. Increased frontal power 
not activity) of low frequency oscillations has been noted 
reviously, albeit at the sensor level, with the GABA en- 
ancing drugs tiagabine and gaboxodol, but not zolpidem 
 Nutt et al., 2015 ). 
Inclusion of template flumazenil V T data allowed us to go 
 step further than quantifying changes in connectivity with 
nhanced GABA, because we were able to demonstrate evi- 
ence that the amount of functional change in a region was 
redicted by that region’s canonical density of GABA A re- 
eptors. This provided a mechanistic link between the drug 
arget and observed response, suggestive of target engage- 
ent. However, to make such an assertation follow-up stud- 
es to explore the specificity of this effect – both by explor- 
ng a PET map of a difference receptor, and by the inclusion 
f a non-GABAergic drug. 42 Although we observed connectivity and activity changes 
cross frequency bands ranging from delta to beta, we ob- 
erved no connectivity changes in the gamma band, even 
hen sub-dividing into discrete 20 Hz windows. One ex- 
lanation for this, is that the GABAergic processes altered 
y tiagabine did not disrupt the generative mechanisms 
f gamma oscillations. However, this is unlikely since the 
eneration of (and spectral characteristics of) gamma os- 
illations are coupled to GABA A dynamics ( Bartos et al., 
007 ; Whittington et al., 2000 ). Instead, we propose that 
amma oscillations, which are considered locally generated 
henomena within cortical columns, are harder to mea- 
ure between-region. This is because gamma oscillations, by 
irtue of being fast, can exist more transiently than lower 
requencies, and are therefore harder to detect when corre- 
ating long amplitude envelopes. If this is the case, methods 
imed at identifying fast dynamical switching, such as Hid- 
en Markov Models, may be more successful for quantifying 
aster frequencies ( Baker et al., 2014 ). 
.1. Limitations 
his study used a template of flumazenil V T derived from ex- 
sting data, and from different subjects to those who took 
art in the tiagabine MEG study. Using averaged PET data as 
 canonical reference map of GABA A density across the brain 
ermitted us to compare to the average distribution of drug 



















































































12757–12763 . ffects across the brain, but lacks the specificity afforded by 
aving PET and MEG on the same individuals. Future stud- 
es should consider this, since having both would allow for 
etailed analysis of individual differences. A caveat here is 
he relative expense and exposure to radioactivity with PET 
ompared with the safety of M/EEG. Future studies should 
lso consider ‘control maps’ derived by PET ligands for other 
eceptor types, which would allow exploration of the speci- 
city of the effect to GABA-A receptor distribution. 
A further limitation related to the use of MEG and PET 
ata from different cohorts is the apparent age gap, where 
he participants in the PET template were on average 
6, whereas the participants in the MEG were on average 
5.5. This raises the question of age as a confound, since 
ABA receptor densities and levels may decline with age 
 Cuypers et al., 2018 ). However, in the case of age-related 
ecline, our study actually made it harder to find a correla- 
ion between the two groups, since the older cohort do not 
ave such a ‘dense’ map as the younger MEG subjects would 
ave. Again, including the same participants in the MEG and 
ET portions of the study would eliminate this confound. 
Our investigation of the spatial co-distribution of activity 
ith FMZ V T may overestimate correlations due to the inher- 
nt smoothness in the PET images. This smoothness-induced 
utocorrelation reduces the effective degrees of freedom, 
hereby rendering inflated statistics in conventional corre- 
ation measures, such as the Pearson’s correlation employed 
ere ( Afyouni et al., 2019 ; Arbabshirani et al., 2014 ). 
. Conclusions 
e have demonstrated that pharmacologically increased 
ABA availability led to increased frontal activity and re- 
uced posterior activity – and inter-region connectivity –
cross multiple frequency bands. The spatially distinct pat- 
ern of activity changes correlated with a template distri- 
ution of GABA A receptors across the brain. We propose a 
echanistic explanation for our results, whereby increased 
ABA availability (by tiagabine) led to increased affinity of 
ABA A receptors for GABA ( Frankle et al., 2009 ), lengthen- 
ng IPSCs ( Thompson and Gähwiler, 1992 ) and consequently 
educing low frequency oscillatory activity and connectivity 
by the lengthened IPSCs ‘dampening’ current fluctuations 
nderpinning macroscopic oscillations). While demonstrat- 
ng a role for GABAergic dynamics in shaping the activity and 
opography of functional connectivity, our results clearly in- 
icate the need for follow-up studies to assess the potential 
tility of MEG-based measures of connectivity and activity 
s tools for time and frequency-resolved electrophysiologi- 
al receptor mapping. 
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